Form 4: Cardio Diagnostics Holdings Director Acquires Stock Options
SEC Form 4 Filing
Director James Intrater acquired 4,544 stock options in Cardio Diagnostics Holdings on December 31, 2024, while disposing of 30,805 stock options.
Summary
- On December 31, 2024, James Intrater, a director of Cardio Diagnostics Holdings, Inc., engaged in transactions involving derivative securities.
- Intrater acquired 4,544 stock options with an exercise price of $0.92.
- These options are exercisable immediately and expire on December 31, 2034.
- Intrater disposed of 30,805 stock options.
- Following these transactions, Intrater beneficially owns 30,805 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock option transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the holdings of company directors. It's a standard practice for publicly traded companies.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of earliest transaction: Acquisition of 4,544 stock options and disposal of 30,805 stock options. |
| 12/31/2024 | Date the acquired stock options are exercisable. |
| 12/31/2034 | Expiration date of the acquired stock options. |
| 01/15/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.